Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia

Eur J Cancer. 1994;30A(9):1259-63. doi: 10.1016/0959-8049(94)90169-4.

Abstract

Serum levels of tumour necrosis factor-alpha (TNF-alpha) have been evaluated in the peripheral blood of 91 patients with B-cell chronic lymphocytic leukaemia (B-CLL), and have been correlated with the clinical stage (according to Rai's staging system) and relevant haematological and immunological data. Increased values were detected, compared to 36 normal age-matched controls (36 pg/ml +/- 5 versus 0.11 pg/ml +/- 0.08; P < 0.05). An increase of TNF-alpha serum levels was observed in all stages including stage 0, with a progressive increase in relation to the stage of the disease. A significant relationship between serum TNF-alpha levels and the number of circulating monocytes (P < 0.002) and an inverse correlation with the level of the haemoglobin (P < 0.001) was established, as defined by the Pearson's correlation test. In contrast, no correlation was observed between TNF-alpha serum levels and the other parameters taken into account, including the white blood cell and platelet counts, the absolute number of peripheral blood (PB) lymphocytes, CD5+ B lymphocytes, CD57+ lymphocytes, serum levels of lactic dehydrogenase, total serum immunoglobulins and the serum levels of IgG, IgA and IgM. These data suggest that, in addition to the B-CLL neoplastic cells, the PB monocytes may be involved in the release of TNF-alpha.

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • Female
  • Hemoglobins / analysis
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukocyte Count
  • Male
  • Middle Aged
  • Monocytes
  • Neoplasm Staging
  • Tumor Necrosis Factor-alpha / analysis*

Substances

  • Biomarkers, Tumor
  • Hemoglobins
  • Tumor Necrosis Factor-alpha